Searchable abstracts of presentations at key conferences in endocrinology

ea0088020 | Abstracts | BES2022

A rare etiology of primary amenorrhea in a 16-year-old girl

E Nauwynck , W Staels , J De Schepper

Introduction: Premature ovarian insufficiency (POI) is a rare cause of primary amenorrhea (1,2). We report a 16-year-old girl with normal secondary sexual characteristics, but no menses due to an autoimmune POI and associated with autoimmune gastritis. This is the first report of such constellation in an adolescent – both conditions separately already being rare in the pediatric population.Case presentation: A 16-year-old girl was referred to our de...

ea0057036 | ACTH independent hypercorticism with normal adrenal imaging and negative genetic screening for micronodular adrenal disease in a female teenager: what to suspect? | BES2018

ACTH independent hypercorticism with normal adrenal imaging and negative genetic screening for micronodular adrenal disease in a female teenager: what to suspect?

Van De Maele K , De Schepper J

Introduction: Micronodular adrenocortical disease is a very rare cause of Cushing syndrome in children. This adrenocorticotropic hormone (ACTH)-independent form of Cushing syndrome is mostly a part of the Carney Complex, which is caused by mutations in the PRKAR1A gene (1). A young female with endogenous ACTH independent hypercorticism without the classical gene mutations in the pigmented and the non-pigmented form of micronodular adrenal disease is presented.<p c...

ea0019s3biog | Society for Endocrinology Transatlantic Medal Lecture | SFEBES2009

Society for Endocrinology Transatlantic Medal Lecture

Jameson J Larry , Dean Lewis Landsberg

J Larry Jameson & Lewis Landsberg Dean, Vice-President for Medical Affairs, Northwestern University, Evanston, Illinois, USA; Feinberg School of Medicine, Northwestern University, Evanston, Illinois, USA AbstractJ Larry Jameson, MD, PhD, received his medical degree with honors and a doctoral degree in biochemistry from the University of North Carolina in 1981. He performed his clinical training in internal medicin...

ea0019p329 | Steroids | SFEBES2009

Testosterone deficiency in the testicular feminised mouse model is significantly associated with the development of liver steatosis: a mechanism that is independent of the androgen receptor

Dugdale C , Nettleship J , Jones TH

To determine the role of testosterone on liver fat deposition using the testicular feminised mouse (Tfm) model. The Tfm does not have a functional androgen receptor (AR) and low circulating levels of testosterone due to associated 17αhydroxylase deficiency.Liver tissue was obtained after 24 weeks of feeding with a cholesterol enriched diet from the following groups: (1) XY placebo-treated (littermate control), (2) Tfm placebo, (3) XY castrate placeb...

ea0057025 | Rare cause of 1,25-dihydroxy vitamin D mediated hypercalcemia: A case report and literature study | BES2018

Rare cause of 1,25-dihydroxy vitamin D mediated hypercalcemia: A case report and literature study

de Bellefroid J , Van den Bruel A , Vandecasteele S

Background: 1,25-dihydroxy vitamin D mediated hypercalcemia resulting from an inflammatory reaction caused by a foreign body such as a textiloma has never been described.Clinical case: A 61 year-old man with a medical history of Alport syndrome and in need of chronic dialysis after transplant kidney resection because of relapsing severe urinary tract infections, presented with recurrent and progressive hypercalcemia two years after parathyroidectomy (C a...

ea0019p269 | Pituitary | SFEBES2009

The management of microprolactinoma: are we following the guidelines for dopamine agonist withdrawal?

Huda M , Wee J , Kwok H , Lawrence U , Moore R , Scally L , Gibbs C , Tremble J

Background: Dopamine agonist (DA) withdrawal is common in the management of microprolactinoma. Guidelines in 19971 and 20062 suggest that DA should be withdrawn after normoprolactinaemia for 3 years.Aims: To assess DA withdrawal and adherence to guidelines.Methods: We retrospectively examined casenotes from 1997 to 2008. Patients were included with clinical and biochemical evidence of hyperprolactinaemia, and ...

ea0007p288 | Clinical case reports | BES2004

Testosterone-replacement stimulated hyperprolactinaemia

Sodi R , Fikri R , Diver M , Ranganath L , Vora J

TESTOSTERONE-REPLACEMENT STIMULATED HYPERPROLACTINAEMIAR Sodi, R Fikri, M Diver, L Ranganath & J Vora*.Departments of Clinical Chemistry and Endocrinology*Royal Liverpool and Broadgreen University Hospital,Liverpool, UK. L7 8XP.Around half of all men with macroprolactinomas have hypogonadism and may require exogenous testosterone replacement. However, testoste...

ea0070aep37 | Adrenal and Cardiovascular Endocrinology | ECE2020

Physiologically based pharmacokinetic modelling to inform dosing in adrenal insufficiency and congenital adrenal hyperplasia

Whitaker Martin J , Bonner Jennifer J , Burt Howard , Johnson Trevor N , Porter John , Ross Richard JM

Background: Replacing physiological cortisol levels is important for the long-term health of patients with adrenal insufficiency and congenital adrenal hyperplasia (CAH). Modified-release formulations of hydrocortisone are one strategy being used to replace the cortisol circadian rhythm in adult patients but there is no data in children. Physiologically based pharmacokinetic (PBPK) modelling is a valuable tool for paediatric drug development1; however, there are no ...

ea0002sp21 | <emphasis>Journal of Molecular Endocrinology</emphasis> Symposium: Receptor Antagonists | SFE2001

Structural Basis of Agonism and Antagonism in the Oestrogen Receptor

Hubbard R , Pike A , Brzozowski A , Bonn T , Carlquist M , Gustafsson J

The oestrogen receptor (ER) is a ligand-inducible transcription factor that controls expression of a number of genes in a wide variety of tissues. Binding of the natural hormone, oestradiol, triggers dimerisation and nuclear location of the receptor and assembly of a functional transcriptional complex through recruitment of various coactivators.In this talk, I will discuss how knowledge of the structure of the receptor has had a major impact on our under...

ea0029p351 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Familial central diabetes insipidus due to a novel mutation in exon 3 of the arginine vasopressin gene

Ritter M. , Gross U. , Feldkamp J. , Hoppner W. , Schulte H.

Neurohypophyseal diabetes insipidus (DI) is said to be caused by familial forms in about 5% of cases1. Hereditary transmission is autosomal dominant in most families and is caused by a mutation in the arginine vasopressin (AVP) gene on chromosome 20p13, which encodes for a large precursor hormone.A 19-years old otherwise healthy patient seeked endocrine care for an inadequately treated DI. He reported about an undoubtful disease history with a...